DCG unveils next generation multi-analyte, AI-powered decision support platform for personalized treatment of difficult-to-treat cancers
Datar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte AI-driven platform providing optimized treatment options for cancer patients who have exhausted the standard options.